Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ivermectin as an inhibitor of cancer stem‑like cells.
Dominguez-Gomez G, Chavez-Blanco A, Medina-Franco JL, Saldivar-Gonzalez F, Flores-Torrontegui Y, Juarez M, Díaz-Chávez J, Gonzalez-Fierro A, Dueñas-González A. Dominguez-Gomez G, et al. Mol Med Rep. 2018 Feb;17(2):3397-3403. doi: 10.3892/mmr.2017.8231. Epub 2017 Dec 8. Mol Med Rep. 2018. PMID: 29257278
Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
Díaz-Chávez J, Fonseca-Sánchez MA, Arechaga-Ocampo E, Flores-Pérez A, Palacios-Rodríguez Y, Domínguez-Gómez G, Marchat LA, Fuentes-Mera L, Mendoza-Hernández G, Gariglio P, López-Camarillo C. Díaz-Chávez J, et al. PLoS One. 2013 May 27;8(5):e64378. doi: 10.1371/journal.pone.0064378. Print 2013. PLoS One. 2013. PMID: 23724044 Free PMC article.
Ribavirin as a tri-targeted antitumor repositioned drug.
De la Cruz-Hernandez E, Medina-Franco JL, Trujillo J, Chavez-Blanco A, Dominguez-Gomez G, Perez-Cardenas E, Gonzalez-Fierro A, Taja-Chayeb L, Dueñas-Gonzalez A. De la Cruz-Hernandez E, et al. Oncol Rep. 2015 May;33(5):2384-92. doi: 10.3892/or.2015.3816. Epub 2015 Feb 25. Oncol Rep. 2015. PMID: 25738706
MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors.
López-Saavedra A, Ramírez-Otero M, Díaz-Chávez J, Cáceres-Gutiérrez R, Justo-Garrido M, Andonegui MA, Mendoza J, Downie-Ruíz Á, Cortés-González C, Reynoso N, Castro-Hernández C, Domínguez-Gómez G, Santibáñez M, Fabián-Morales E, Pruefer F, Luna-Maldonado F, González-Barrios R, Herrera LA. López-Saavedra A, et al. Cell Cycle. 2016 Aug 2;15(15):2066-76. doi: 10.1080/15384101.2016.1198863. Epub 2016 Jun 17. Cell Cycle. 2016. PMID: 27315568 Free PMC article.
Viral inhibitors of NKG2D ligands for tumor surveillance.
Chávez-Blanco A, Chacón-Salinas R, Dominguez-Gomez G, Gonzalez-Fierro A, Perez-Cardenas E, Taja-Chayeb L, Trejo-Becerril C, Duenas-Gonzalez A. Chávez-Blanco A, et al. Expert Opin Ther Targets. 2016 Nov;20(11):1375-1387. doi: 10.1080/14728222.2016.1202928. Epub 2016 Jun 29. Expert Opin Ther Targets. 2016. PMID: 27322108 Review.
Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.
Cervantes-Madrid D, Dominguez-Gomez G, Gonzalez-Fierro A, Perez-Cardenas E, Taja-Chayeb L, Trejo-Becerril C, Duenas-Gonzalez A. Cervantes-Madrid D, et al. Oncol Lett. 2017 Mar;13(3):1905-1910. doi: 10.3892/ol.2017.5615. Epub 2017 Jan 18. Oncol Lett. 2017. PMID: 28454342 Free PMC article.
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Schcolnik-Cabrera A, Chávez-Blanco A, Domínguez-Gómez G, Taja-Chayeb L, Morales-Barcenas R, Trejo-Becerril C, Perez-Cardenas E, Gonzalez-Fierro A, Dueñas-González A. Schcolnik-Cabrera A, et al. Expert Opin Investig Drugs. 2018 May;27(5):475-489. doi: 10.1080/13543784.2018.1471132. Epub 2018 May 10. Expert Opin Investig Drugs. 2018. PMID: 29723075 Review.
37 results